Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Phoenix Financial Ltd. ITRN Ituran Location & Control Ltd. 13G/A 4.98% 2y
Lytton, Laurence W. BFRI Biofrontera Inc. 13G 9.99% 2y
Orin Hirschman BFRI Biofrontera Inc. 13G 9.9% 2y
ATS Brand Sdn Bhd. XMAX XMax Inc. 13G 12.9% 2y
Hasson Heather L. FIGS FIGS, Inc. 13D/A 9.55% 2y
Findell Capital Partners LP OPRT Oportun Financial Corp 13D/A 7.7% 2y
Eugenio Santiago Clariond Reyes BY Byline Bancorp, Inc. 13G/A 4.6% 2y
Spear Catherine Eva FIGS FIGS, Inc. 13D/A 12.64% 2y
Pfizer Inc HLN Haleon plc 13D/A 32% 2y
Leviticus Partners LP FRSX Foresight Autonomous Holdings Ltd. 13G/A 5.97% 2y
Bertelsmann SE & Co. KGaA AFYA Afya Ltd 13D/A 60.1% 2y
Leviticus Partners LP HBIO Harvard Bioscience Inc 13G 5.32% 2y
BML Investment Partners, L.P. CYT Cyteir Therapeutics, Inc. Common Stock 13G/A 10.6% 2y
Ted Karkus PRPH ProPhase Labs, Inc. 13D/A 20.3% 2y
Beijing Zhenwei Qingfeng Economic Management Consulting Partnership (L.P.) NAAS NaaS Technology Inc. 13D/A 9.86% 2y
Standard General L.P. BALY Bally's Corp 13D/A 26.4% 2y
Charles F. Dolan MSGE Madison Square Garden Entertainment Corp. 13D/A 9.3% 2y
Starboard Value LP ALIT Alight, Inc. / Delaware 13D/A 7.3% 2y
Great Hill Equity Partners IV, L.P. INTA Intapp, Inc. 13D/A 9.2% 2y
William J. Colombo DKS Dick's Sporting Goods, Inc. 13D/A 13.77% 2y
Synchron REEMF Rare Element Resources Ltd 13D/A 70.6% 2y
Jonathan H. Kaufman LIPO Lipella Pharmaceuticals Inc. 13D/A 21% 2y
Fund 1 Investments, LLC TLYS Tilly's, Inc. 13D/A 33.87% 2y
MILLENNIUM MANAGEMENT LLC BGC BGC Group, Inc. 13G 0.6% 2y
David Brody XTIA XTI Aerospace, Inc. 13D 25.52% 2y
de Rothschild Robert PNRG Primeenergy Resources Corp 13D/A 16.2% 2y
Philadelphia Financial Management of San Francisco, LLC MCHB Mechanics Bancorp 13G 5.3% 2y
Quogue Capital LLC IOVA Iovance Biotherapeutics, Inc. 13D/A 11.6% 2y
CONTINENTAL GENERAL INSURANCE CO AMR Alpha Metallurgical Resources, Inc. 13D/A 10.7% 2y
Memphis Equity Ltd SWVL Swvl Holdings Corp 13D 10.53% 2y
ICAHN CARL C UAN Cvr Partners, LP 13D 36.8% 2y
Nirav Tolia NXDR Nextdoor Holdings, Inc. 13D/A 13.2% 2y
ICAHN CARL C CVI Cvr Energy Inc 13D/A 66.3% 2y
Cove Street Capital, LLC TBRG TruBridge, Inc. 13G 5.06% 2y
Dmitry Genkin XBIO Xenetic Biosciences, Inc. 13D/A 14% 2y
JAB BevCo B.V. KDP Keurig Dr Pepper Inc. 13D/A 21% 2y
Saba Capital Management, L.P. DSM Bny Mellon Strategic Municipal Bond Fund, Inc. 13D/A 6.23% 2y
Cano Health, Inc. MSPR MSP Recovery, Inc. 13D/A 15.6% 2y
Saba Capital Management, L.P. LGI Lazard Global Total Return & Income Fund Inc 13D 5.02% 2y
Corvex Management LP MDU Mdu Resources Group Inc 13D/A 4.98% 2y
Dominion Capital LLC HUBC Hub Cyber Security Ltd. 13D 4.6% 2y
NOVO HOLDINGS A/S SPRB Spruce Biosciences, Inc. 13D/A 15.1% 2y
Topline Capital Management, LLC ACCS ACCESS Newswire Inc. 13G/A 14.5% 2y
FS Capital Partners VI, LLC ARHS Arhaus, Inc. 13D/A 0.47% 2y
RA CAPITAL MANAGEMENT, L.P. CLYM Climb Bio, Inc. 13D/A 47.5% 2y
CAS Investment Partners, LLC CDLX Cardlytics, Inc. 13D/A 13.7% 2y
Pinetree Capital Ltd. TBRG TruBridge, Inc. 13D/A 9.7% 2y
Saba Capital Management, L.P. CPZ Calamos Long/Short Equity & Dynamic Income Trust 13D 5.07% 2y
MILLENNIUM MANAGEMENT LLC MYGN Myriad Genetics Inc 13G 4.7% 2y
D. E. Shaw & Co., L.P. OPTU Optimum Communications, Inc. 13G 5% 2y